Acorah Software Products - Accounts Production15.0.500falsetruefalsetrueNo description of principal activity5 December 202231 December 202331 December 202314523033Mr Tsz Chung TYiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure145230332022-12-04145230332023-12-31145230332022-12-052023-12-3114523033frs-core:CurrentFinancialInstruments2023-12-3114523033frs-bus:PrivateLimitedCompanyLtd2022-12-052023-12-3114523033frs-bus:FilletedAccounts2022-12-052023-12-3114523033frs-bus:Micro-entities2022-12-052023-12-3114523033frs-bus:AuditExempt-NoAccountantsReport2022-12-052023-12-3114523033frs-bus:Director12022-12-052023-12-31
Registered number: 14523033
JASMINE THERAPY LIMITED
Financial Statements
For the Period 5 December 2022 to 31 December 2023
JASMINE THERAPY LIMITED
Balance Sheet
As At 31 December 2023
Balance Sheet
Registered number: 14523033
31 December 2023
£
Current assets
1,234
Creditors: Amounts Falling Due Within One Year
(4,811)
NET CURRENT LIABILITIES
(3,577)
TOTAL ASSETS LESS CURRENT LIABILITIES
(3,577)
NET LIABILITIES
(3,577)
CAPITAL AND RESERVES
(3,577)
Notes
1.General Information
JASMINE THERAPY LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 14523033. The registered office is 95 Buxton Road, Stockport, SK2 6LR.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.